There are various reasons for this, including the high cost and limited access to the drugs, but side effects particularly nausea may cause some people to give up on their medications before they reach their weight loss goals or improve their Type 2 diabetes
Visit the DSIP Category Page United Kingdom for other product formulations, including more information about the benefits of this peptide
In what seems like a trade-off between weight loss and hair loss, a new study has found that the glucagon-like peptide-1 (GLP-1) receptor agonists commonly called weight-loss drugs used to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults
Diabetes Obes Metab 21(7):17451751
Out of 29 peptide entries from DrugBank, 6 entries were mapped to PDB, 9 entries were predicted using PEPstrMOD, and the rest 14 entries with modified residues were not predicted
However, glycemic control per se cannot fully prevent or improve DPN, especially in patients with type 2 diabetes mellitus (T2DM) [6-8]
